Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PEST-containing nuclear protein (PCNP) is a short-lived, small nuclear protein (178 amino acids) characterized by the presence of two PEST sequence motifs rich in proline, glutamic acid, serine, and threonine. It plays a critical role in the regulation of the cell cycle, apoptosis, and tumorigenesis across several cancer types by participating in the ubiquitin-proteasome degradation pathway and interacting with regulatory proteins like p53 and NIRF. PCNP modulates key cancer-related pathways, including MAPK, PI3K/AKT/mTOR, and Wnt/β-catenin, and is involved in epigenetic silencing through interactions with histone deacetylases and methyltransferases. Due to its central role in cancer cell proliferation and apoptosis, PCNP is considered a promising, though not yet drugged, target for cancer diagnostics and therapeutics; targeting its stability, ubiquitination, and interactions may represent a novel class of anti-cancer strategies.
Targeting protein stability via ubiquitination/proteasome degradation Modulating post-translational modifications affecting cell cycle/apoptosis Epigenetic silencing of oncogenes or tumor suppressors
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PEST-containing nuclear protein (PCNP).